Loading...
Loading...
Of the 4 tracked institutions holding SOPH, 3 have a 3-year clone track record — 2 of them beat the S&P. Average holder's clone alpha: +0.7pt. It's a gauge of who owns the name, not just how many.
Alpha = the manager's 3-year clone return minus the S&P 500. A skilled roster is a stronger tell than a crowded one — though even skilled managers' edge doesn't reliably survive the 13F disclosure lag. Why →
Among the 4 tracked institutional investors we monitor, SOPH (SOPHIA GENETICS SA) is held with a combined value of $18.78M across 3,794,168 shares. The largest holder is AKRE CAPITAL MANAGEMENT LLC with a position worth $18.41M (0.30% of their portfolio). 2 funds reduced their position.
Total Institutional Value
$18.78M
Total Shares Held
3,794,168
Institutional Holders
4
Ranked by estimated dollars moved (share change × implied price). 13F data lags up to 45 days.
None this quarter.
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | AKRE CAPITAL MANAGEMENT LLC | $18.41M | 0.30% | - |
| 2 | RENAISSANCE TECHNOLOGIES LLC | $296.01K | 0.00% | -28.0% |
| 3 | MILLENNIUM MANAGEMENT LLC | $50.20K | 0.00% | -91.9% |
| 4 | BlackRock, Inc. | $25.18K | 0.00% | - |
As of the latest SEC 13F filings, AKRE CAPITAL MANAGEMENT LLC is the largest institutional holder of SOPH with a position worth $18.41M, representing 0.30% of their portfolio. In total, 4 institutional investors hold SOPH with a combined value of $18.78M.
Institutional investors hold $18.78M worth of SOPH stock across 4 positions. The largest institutional holder is AKRE CAPITAL MANAGEMENT LLC with $18.41M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For SOPH, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their SOPH positions.
Last Close
$5.72
2026-07-24
YTD
+22.5%
78% of 52-week range